# EDGAR Filing Document

**Accession Number:** 0001336920
**File Stem:** 0001336920-25-000057
**Filing Date:** 2025-11
**Character Count:** 60689
**Document Hash:** 625550d235e4990ccbed549ced4066f6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001336920-25-000057.hdr.sgml**: 20251104

**ACCESSION NUMBER**: 0001336920-25-000057

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20251104

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251104

**DATE AS OF CHANGE**: 20251103

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Leidos Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001336920
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 203562868
- **FISCAL YEAR END:** 0102

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33072
- **FILM NUMBER:** 251445809

**BUSINESS ADDRESS:**
- **STREET 1:** 1750 PRESIDENTS STREET
- **CITY:** RESTON
- **STATE:** VA
- **ZIP:** 20190
- **BUSINESS PHONE:** 571-526-6000

**MAIL ADDRESS:**
- **STREET 1:** 1750 PRESIDENTS STREET
- **CITY:** RESTON
- **STATE:** VA
- **ZIP:** 20190

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SAIC, Inc.
- **DATE OF NAME CHANGE:** 20050823

?xml version='1.0' encoding='ASCII'? ldos-20251104

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of**

**the Securities Exchange Act of 1934**

**Date of Report (Date of Earliest Event Reported): November 4, 2025**

---

| |
|:---|
| **LEIDOS HOLDINGS, INC.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Delaware** | **Delaware** | **Delaware** | **001-33072** | **20-3562868** |
| (State or other jurisdiction of incorporation or organization) | (State or other jurisdiction of incorporation or organization) | (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| **1750 Presidents Street,** | **Reston,** | **Virginia** | | **20190** |
| (Address of principal executive office) | (Address of principal executive office) | (Address of principal executive office) | | (Zip Code) |

---

**(571) 526-6000** 

(Registrants' telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading symbol(s) | Name of each exchange on which registered |
| Common stock, par value $.0001 per share | LDOS | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**FORM 8-K**

---

| | |
|:---|:---|
| **Item 2.02.** | **Results of Operations and Financial Condition.** |

---

On November 4, 2025, Leidos Holdings, Inc. (the "Company") issued a press release announcing its financial results for the third fiscal quarter ended October 3, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report.

The Company's management will discuss operations and financial results in an earnings conference call beginning at 8:00 a.m. eastern on November 4, 2025. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company's web site (<u>http://investors.leidos.com</u>).

The information contained in Item 2.02 of this report and Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits.** |

---

&nbsp;&nbsp;&nbsp;&nbsp;*(i) Exhibits*

---

| | |
|:---|:---|
| Exhibit 99.1 | <u>[Press Release dated October 3, 2025, issued by Leidos Holdings, Inc.](ldos100325q3pressreleaseex.htm)</u> |
| Exhibit 104 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL and contained in Exhibit 101. |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | **LEIDOS HOLDINGS, INC.** | **LEIDOS HOLDINGS, INC.** |
| Date: | November 4, 2025 | By: | /s/ Christopher R. Cage |
|  |  |  | Christopher R. Cage |
|  |  | Its: | Executive Vice President and Chief Financial Officer |

---

## Exhibit 99.1

**EXHIBIT 99.1**

**Leidos Posts Strong Third Quarter Results and Raises Full-Year Guidance** 

►Record Revenues of $4.5 billion, up 7% year-over-year, including 6% organically

►Net income of $369 million or $2.82 per diluted share

►Adjusted EBITDA (non-GAAP) of $616 million and Adjusted EBITDA margin (non-GAAP) of 13.8%

►Non-GAAP Diluted Earnings per Share of $3.05, up 4% year-over-year

►Cash Flows from Operations of $711 million; Non-GAAP Free Cash Flow of $680 million

RESTON, Va., November 4, 2025 – Leidos Holdings, Inc. (NYSE: LDOS) today reported financial results for the third quarter of fiscal year 2025, highlighted by robust earnings and revenue growth.

"Leidos continues to deliver exceptional results through the strength of our portfolio of mission-critical work as well as the innovation, agility, and discipline of our talented workforce," said Leidos Chief Executive Officer Tom Bell. "Despite the government shutdown, we are raising our 2025 earnings and margin guidance and holding firm on our 2025 revenue and cash guidance. Moreover, we are optimistic about our future given our alignment with the priorities of the administration and confidence that our customers will move out aggressively in search of smarter and more efficient outcomes for the nation."

**SUMMARY OPERATING RESULTS**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| (in millions, except margin and per share data) | **October 3, 2025** | September 27, 2024 |
| Revenues | $**4469** | $4190 |
| Net income | $**369** | $362 |
| Net income margin | **8.3%** | 8.6% |
| Diluted earnings per share (EPS) | $**2.82** | $2.68 |
| *Non-GAAP Measures\*:* |  |  |
| Adjusted EBITDA | $**616** | $596 |
| Adjusted EBITDA margin | **13.8%** | 14.2% |
| Non-GAAP diluted EPS | $**3.05** | $2.93 |
| \* Non-GAAP financial measures should be considered in addition to, but not as a substitute for, the information provided in accordance with GAAP. Management believes that these non-GAAP measures provide another representation of Leidos' results of operations and financial condition, including its ability to comply with financial covenants. See Non-GAAP Financial Measures at the end of this press release for more information and a reconciliation of our selected reported results to these non-GAAP measures. | \* Non-GAAP financial measures should be considered in addition to, but not as a substitute for, the information provided in accordance with GAAP. Management believes that these non-GAAP measures provide another representation of Leidos' results of operations and financial condition, including its ability to comply with financial covenants. See Non-GAAP Financial Measures at the end of this press release for more information and a reconciliation of our selected reported results to these non-GAAP measures. | \* Non-GAAP financial measures should be considered in addition to, but not as a substitute for, the information provided in accordance with GAAP. Management believes that these non-GAAP measures provide another representation of Leidos' results of operations and financial condition, including its ability to comply with financial covenants. See Non-GAAP Financial Measures at the end of this press release for more information and a reconciliation of our selected reported results to these non-GAAP measures. |

---

Revenues for the quarter were $4.47 billion, up 7% compared to the third quarter of 2024. Revenues grew year-over-year due to increased customer demand, especially for innovative products and solutions for national security and defense missions.

For the third quarter, net income was $369 million, or $2.82 per diluted share. Net income and diluted EPS were up 2% and 5% year-over-year, respectively. Net income margin of 8.3% decreased from 8.6% in the third quarter of 2024.

Adjusted EBITDA was $616 million for the third quarter, up 3% year-over-year. Adjusted EBITDA margin of 13.8% decreased from 14.2% in the third quarter of 2024. Non-GAAP net income was $399 million for the third quarter, up 1% year-over-year, and non-GAAP diluted EPS for the quarter was $3.05, up 4% year-over-year. Profitability remained high despite a $24 million increase to legal reserves through prudent cost management and excellent award and incentive fee performance.

**CASH FLOW SUMMARY**

In the third quarter, Leidos generated $711 million of net cash provided by operating activities and used $36 million and $595 million in investing and financing activities, respectively. Net cash provided by operating activities was driven by strong EBITDA and collections performance. Days Sales Outstanding (DSO) for the quarter was 60.

Investing activities consisted primarily of $31 million in property, equipment and software payments, which resulted in quarterly free cash flow of $680 million. Financing activities were driven by term loan principal payments of $450 million and return to

1 Leidos Holdings, Inc. Exhibit 99.1

------

shareholders of $153 million, including $102 million in share repurchases and $51 million as part of a regular quarterly cash dividend program. As of October 3, 2025, Leidos had $974 million in cash and cash equivalents and $4.7 billion of debt.

On October 31, 2025, the Leidos Board of Directors declared a cash dividend of $0.43 per share, which represents an increase of 7.5% over the prior quarter's dividend amount. The dividend will be payable on December 31, 2025, to stockholders of record at the close of business on December 15, 2025.

Leidos Holdings, Inc. Exhibit 99.1 2

------

**NEW BUSINESS AWARDS**

Net bookings totaled $5.9 billion in the quarter, representing a book-to-bill ratio of 1.3. As a result, backlog at the end of the quarter was $47.7 billion, of which $9.1 billion was funded. Total backlog was up 5% year-over-year, and funded backlog was up 27% sequentially. Included in the quarterly bookings were several notable awards:

►**Classified Mission Support.** Leidos was awarded a $2.2 billion, seven-year contract in the intelligence community. This take-away award demonstrates Leidos' capability and commitment in supporting the most critical missions to protect the nation.

►**National Aeronautics and Space Administration (NASA) Human Health and Performance Contract.** Leidos received a $760 million single award indefinite delivery indefinite quantity (IDIQ) subcontract to provide critical astronaut health and performance services and research support to enable NASA to prepare for the next era of human space exploration. This work supports NASA's advancement of space exploration for low-Earth-orbit and Artemis missions, ensuring astronauts advance further, for longer durations, and return home safely.

►**Classified Mission Software & IT Support.** Leidos secured a $540 million, seven-year contract to continue to enhance and maintain mission-critical, AI-enabled software for Counter Terrorism efforts.

►**Naval Undersea Warfare Center (NUWC) Naval Array Technical Support Center (NATSC) Services. The** NUWC awarded Leidos a five-year contract with a ceiling value of $188 million to continue to provide engineering, maintenance, logistics, and quality assurance support for undersea warfare towed array systems. Under the new contract, Leidos will strengthen NATSC operations by implementing new training best practices and actively managing the supply chain to detect counterfeit components and secure alternative suppliers for obsolete parts.

►**Kazakhstan Air Traffic Management.** Building on more than 20 years of support, Leidos will modernize the Republic of Kazakhstan's air traffic control system to accommodate significant expansion in the country's aviation sector. Leidos will upgrade the systems that help air traffic controllers safely manage planes on the ground and in the air. In addition, Leidos will install its SkyLine-X Air Traffic Management system that will provide end-to-end surveillance, improved safety and streamlined operations through a common automation platform with a modular and open architecture. The agreement has a 19-year period of performance and includes work at four control centers and 21 towers across the country.

►**DOD Healthcare Management System Modernization (DHMSM).** The Defense Health Agency awarded Leidos a one-year, $370 million contract to continue to provide operational support and maintain performance stability for the enterprise baseline, including the "My Military Health" hybrid care platform. This award strengthens Leidos' position as a trusted partner in delivering advanced digital capabilities and managed health services to the Department of War and the nation's service members.

3 Leidos Holdings, Inc. Exhibit 99.1

------

**FORWARD GUIDANCE**

Leidos is raising its fiscal year 2025 guidance as follows:

---

| | | |
|:---|:---|:---|
| | **FY25 Guidance** | **FY25 Guidance** |
| **Measure** | **Current** | **Prior** |
| Revenues (B) | $17.00 - $17.25 | $17.00 - $17.25 |
| Adjusted EBITDA Margin | High 13% | Mid 13% |
| Non-GAAP Diluted EPS | $11.45 - $11.75 | $11.15 - $11.45 |
| Cash Flows Provided by Operating Activities (B) | Approximately $1.65 | Approximately $1.65 |

---

For information regarding adjusted EBITDA margin and non-GAAP diluted EPS, see the related explanations and reconciliations to GAAP measures included elsewhere in this release.

Leidos does not provide a reconciliation of forward-looking adjusted EBITDA margins or non-GAAP diluted EPS to net income margin or diluted EPS due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Because certain deductions for non-GAAP exclusions used to calculate projected net income margin or diluted EPS may vary significantly based on actual events, Leidos is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income at this time. The amounts of these deductions may be material and, therefore, could result in projected net income margin and diluted EPS being materially less than what may be implied by projected adjusted EBITDA margins and non-GAAP diluted EPS.

Leidos Holdings, Inc. Exhibit 99.1 4

------

**CONFERENCE CALL INFORMATION**

Leidos management will discuss operations and financial results in an earnings conference call beginning at 8 A.M. eastern time on November 4, 2025. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Leidos Investor Relations website (**http://ir.leidos.com**). An archived version of the webcast will be available on the Leidos Investor Relations website until November 4, 2026.

**ABOUT LEIDOS**

Leidos is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations. Headquartered in Reston, Virginia, with 47,000 global employees, Leidos reported annual revenues of approximately $16.7 billion for the fiscal year ended January 3, 2025. For more information, visit **www.leidos.com**.

**FORWARD-LOOKING STATEMENTS**

Certain statements in this release contain or are based on "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "expects," "intends," "plans," "anticipates," "believes," "estimates," "guidance" and similar words or phrases. Forward-looking statements in this release include, among others, estimates of our future growth, strategy and financial and operating performance, including future revenues, adjusted EBITDA margins, diluted EPS (including on a non-GAAP basis) and cash flows provided by operating activities, as well as statements about our business contingency plans, government budgets and spending, the U.S. government shutdown, uncertainties in tax due to new tax legislation or other regulatory developments, strategy, planned investments, sustainability goals and our future dividends, share repurchases, capital expenditures, debt repayments, acquisitions, dispositions and cash flow conversion. These statements reflect our belief and assumptions as to future events that may not prove to be accurate.

Actual performance and results may differ materially from those results anticipated by our guidance and other forward-looking statements made in this release depending on a variety of factors, including, but not limited to: developments in the U.S. government defense and non-defense budgets, including budget reductions, sequestration, implementation of spending limits or changes in budgetary priorities, continuation of the U.S. government shutdown and other or future delays in the U.S. government budget process, or the U.S. government's failure to raise the debt ceiling, which increases the possibility of a default by the U.S. government on its debt obligations, related credit-rating downgrades, or an economic recession; uncertainties in tax due to new tax legislation or other regulatory developments; deterioration of economic conditions or weakening in credit or capital markets; uncertainty in the consequences of current and future geopolitical events; inflationary pressures and fluctuations in interest rates; delays in the U.S. government contract procurement process or the award of contracts and delays or loss of contracts as a result of competitor protests; changes in U.S. government procurement rules, regulations and practices; our compliance with various U.S. government and other government procurement rules and regulations; governmental reviews, audits and investigations of our company; our ability to effectively compete and win contracts with the U.S. government and other customers; our ability to respond rapidly to emerging technology trends, including the use of artificial intelligence; our reliance on information technology spending by hospitals/healthcare organizations; our reliance on infrastructure investments by industrial and natural resources organizations; energy efficiency and alternative energy sourcing investments; investments by U.S. government and commercial organizations in environmental impact and remediation projects; the effects of an epidemic, pandemic or similar outbreak may have on our business, financial position, results of operations and/or cash flows; our ability to attract, train and retain skilled employees, including our management team, and to obtain security clearances for our employees; our ability to accurately estimate costs, including cost increases due to inflation, associated with our firm-fixed-price contracts and other contracts; resolution of legal and other disputes with our customers and others or legal or regulatory compliance issues; cybersecurity, data security or other security threats, system failures or other disruptions of our business; our compliance with international, federal, state and local laws and regulations regarding privacy, data security, protection, storage, retention, transfer, disposal and other processing, technology protection and personal information; the damage and disruption to our business resulting from natural disasters and the effects of climate change; our ability to effectively acquire businesses and make investments; our ability to maintain relationships with prime contractors, subcontractors and joint venture partners; our ability to manage performance and other risks related to customer contracts; the failure of our inspection or detection systems to detect threats; the adequacy of our insurance programs, customer indemnifications or other liability protections designed to protect us from significant product or other liability claims, including cybersecurity attacks; our ability to manage risks associated with our international business; our ability to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010 and similar worldwide anti-corruption and anti-bribery laws and regulations; our ability to protect our intellectual property and other proprietary rights by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to prevail in litigation brought by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our

5 Leidos Holdings, Inc. Exhibit 99.1

------

ability to declare or increase future dividends based on our earnings, financial condition, capital requirements and other factors, including compliance with applicable law and our agreements; our ability to grow our commercial health and infrastructure businesses, which could be negatively affected by budgetary constraints faced by hospitals and by developers of energy and infrastructure projects; our ability to successfully integrate acquired businesses; and our ability to execute our business plan and long-term management initiatives effectively and to overcome these and other known and unknown risks that we face.

These are only some of the factors that may affect the forward-looking statements contained in this release. For further information concerning risks and uncertainties associated with our business, please refer to the filings we make from time to time with the U.S. Securities and Exchange Commission (SEC), including the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Legal Proceedings" sections of our latest Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, all of which may be viewed or obtained through the Investor Relations section of our website at **www.leidos.com**.

All information in this release is as of November 4, 2025. Leidos expressly disclaims any duty to update the guidance or any other forward-looking statement provided in this release to reflect subsequent events, actual results or changes in Leidos' expectations. Leidos also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.

---

| | |
|:---|:---|
| CONTACTS: | |
| Investor Relations: | Media Relations: |
| Stuart Davis | Brandon Ver Velde |
| 571.526.6124 | 571.526.6257 |
| **ir@leidos.com** | **brandon.p.vervelde@leidos.com** |

---

Leidos Holdings, Inc. Exhibit 99.1 6

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| (in millions, except per share data) | **October 3,<br>2025** | September 27,<br>2024 | **October 3,<br>2025** | September 27,<br>2024 |
| Revenues | $**4469** | $4190 | $**12967** | $12297 |
| &nbsp;&nbsp;&nbsp;Cost of revenues | **3648** | 3428 | **10607** | 10192 |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | **286** | 247 | **733** | 704 |
| &nbsp;&nbsp;&nbsp;Acquisition, integration and restructuring costs | **4** | 3 | **10** | 14 |
| &nbsp;&nbsp;&nbsp;Asset impairment charges | **4** | 6 | **4** | 6 |
| &nbsp;&nbsp;&nbsp;Equity earnings of non-consolidated subsidiaries | **(8)** | (10) | **(23)** | (25) |
| Operating income | **535** | 516 | **1636** | 1406 |
| &nbsp;&nbsp;&nbsp;Non-operating income (expense): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense, net | **(51)** | (46) | **(155)** | (146) |
| &nbsp;&nbsp;&nbsp;Other (expense) income, net | **—** |  | **(1)** | 4 |
| Income before income taxes | **484** | 470 | **1480** | 1264 |
| Income tax expense | **(115)** | (108) | **(353)** | (295) |
| Net income | **369** | 362 | **1127** | 969 |
| Less: net income (expense) attributable to non-controlling interest | **2** | (2) | **6** | (1) |
| Net income attributable to Leidos common stockholders | $**367** | $364 | $**1121** | $970 |
| Earnings per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $**2.87** | $2.72 | $**8.69** | $7.19 |
| &nbsp;&nbsp;&nbsp;Diluted | **2.82** | 2.68 | **8.62** | 7.13 |
| Weighted average number of common shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | **128** | 134 | **129** | 135 |
| &nbsp;&nbsp;Diluted | **130** | 136 | **130** | 136 |
| Cash dividends declared per share | $**0.40** | $0.38 | $**1.20** | $1.14 |

---

7 Leidos Holdings, Inc. Exhibit 99.1

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
| (in millions, except share and per share data) | **October 3,<br>2025** | January 3,<br>2025 |
| Assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**974** | $849 |
| &nbsp;&nbsp;&nbsp;Receivables, net | **2970** | 2645 |
| &nbsp;&nbsp;&nbsp;Inventory, net | **360** | 315 |
| &nbsp;&nbsp;&nbsp;Other current assets | **545** | 525 |
| &nbsp;&nbsp;&nbsp;Total current assets | **4849** | 4334 |
| &nbsp;&nbsp;&nbsp;Property, plant and equipment, net | **963** | 991 |
| &nbsp;&nbsp;&nbsp;Intangible assets, net | **496** | 517 |
| &nbsp;&nbsp;&nbsp;Goodwill | **6342** | 6084 |
| &nbsp;&nbsp;&nbsp;Operating lease right-of-use assets, net | **512** | 560 |
| &nbsp;&nbsp;Deferred tax assets | **32** | 203 |
| &nbsp;&nbsp;&nbsp;Other long-term assets | **348** | 321 |
| Total assets | $**13542** | $13010 |
| Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $**2158** | $2131 |
| &nbsp;&nbsp;&nbsp;Accrued payroll and employee benefits | **809** | 811 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt | **19** | 618 |
| &nbsp;&nbsp;&nbsp;Total current liabilities | **2986** | 3560 |
| &nbsp;&nbsp;&nbsp;Long-term debt, net of current portion | **4632** | 4052 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities | **578** | 621 |
| &nbsp;&nbsp;Deferred tax liabilities | **122** | 2 |
| &nbsp;&nbsp;&nbsp;Other long-term liabilities | **270** | 315 |
| Total liabilities | **8588** | 8550 |
| Stockholders' equity: |  |  |
| Common stock, $0.0001 par value, 500,000,000 shares authorized, 127,854,145 and 131,163,899 shares issued and outstanding at October 3, 2025, and January 3, 2025, respectively | **—** |  |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | **588** | 1112 |
| &nbsp;&nbsp;&nbsp;Retained earnings | **4375** | 3410 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(54)** | (110) |
| Total Leidos stockholders' equity | **4909** | 4412 |
| &nbsp;&nbsp;&nbsp;Non-controlling interest | **45** | 48 |
| Total stockholders' equity | **4954** | 4460 |
| Total liabilities and stockholders' equity | $**13542** | $13010 |

---

Leidos Holdings, Inc. Exhibit 99.1 8

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| (in millions) | **October 3,<br>2025** | September 27,<br>2024 | **October 3,<br>2025** | September 27,<br>2024 |
| Cash flows from operations: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net income | $**369** | $362 | $**1127** | $969 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operations: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | **74** | 71 | **215** | 211 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | **26** | 19 | **72** | 59 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | **88** | (29) | **288** | (96) |
| &nbsp;&nbsp;&nbsp;Asset impairment charges | **4** | 6 | **4** | 6 |
| &nbsp;&nbsp;&nbsp;Other | **3** | 3 | **3** | 5 |
| Change in assets and liabilities, net of effects of acquisition: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Receivables | **(61)** | (75) | **(297)** | (260) |
| &nbsp;&nbsp;&nbsp;Other current assets and other long-term assets | **60** | 95 | **26** | 102 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities and other long-term liabilities | **152** | 16 | **(108)** | (101) |
| &nbsp;&nbsp;&nbsp;Accrued payroll and employee benefits | **(17)** | 198 | **(10)** | 208 |
| &nbsp;&nbsp;&nbsp;Income taxes receivable/payable | **13** | (19) | **(65)** | 38 |
| Net cash provided by operating activities | **711** | 647 | **1255** | 1141 |
| Cash flows from investing activities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Acquisition of a business, net of cash acquired | **(7)** |  | **(292)** |  |
| &nbsp;&nbsp;&nbsp;Payments for property, equipment and software | **(31)** | (23) | **(82)** | (63) |
| &nbsp;&nbsp;&nbsp;Other | **2** |  | **2** | 7 |
| Net cash used in investing activities | **(36)** | (23) | **(372)** | (56) |
| Cash flows from financing activities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from debt issuance | **—** |  | **997** |  |
| &nbsp;&nbsp;&nbsp;Repayments of borrowings | **(455)** | (5) | **(1014)** | (14) |
| &nbsp;&nbsp;&nbsp;Payments for debt issuance costs | **—** |  | **(7)** |  |
| &nbsp;&nbsp;&nbsp;Dividend payments | **(51)** | (51) | **(156)** | (155) |
| &nbsp;&nbsp;&nbsp;Repurchases of stock and other | **(102)** | (203) | **(639)** | (500) |
| &nbsp;&nbsp;&nbsp;Proceeds from issuances of stock | **16** | 2 | **47** | 28 |
| &nbsp;&nbsp;&nbsp;Net capital distributions to non-controlling interests | **(2)** |  | **(9)** | (3) |
| &nbsp;&nbsp;&nbsp;Other | **(1)** |  | **(7)** |  |
| &nbsp;&nbsp;&nbsp;Net cash used in financing activities | **(595)** | (257) | **(788)** | (644) |
| &nbsp;&nbsp;&nbsp;Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | **(3)** | 9 | **11** | 5 |
| Net increase in cash, cash equivalents and restricted cash | **77** | 376 | **106** | 446 |
| Cash, cash equivalents and restricted cash at beginning of period | **1020** | 862 | **991** | 792 |
| Cash, cash equivalents and restricted cash at end of period | **1097** | 1238 | **1097** | 1238 |
| &nbsp;&nbsp;&nbsp;Less: restricted cash at end of period | **123** | 141 | **123** | 141 |
| Cash and cash equivalents at end of period | $**974** | $1097 | $**974** | $1097 |

---

9 Leidos Holdings, Inc. Exhibit 99.1

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED SEGMENT OPERATING RESULTS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Nine Months Ended** | **Nine Months Ended** |
| (in millions) | **October 3,<br>2025** | September 27,<br>2024 | **October 3,<br>2025** | September 27,<br>2024 |
| Revenues: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;National Security & Digital | $**2015** | $1865 | $**5765** | $5471 |
| &nbsp;&nbsp;&nbsp;Health & Civil | **1301** | 1225 | **3864** | 3687 |
| &nbsp;&nbsp;&nbsp;Commercial & International | **571** | 578 | **1705** | 1648 |
| &nbsp;&nbsp;&nbsp;Defense Systems | **582** | 522 | **1633** | 1491 |
| Total | $**4469** | $4190 | $**12967** | $12297 |
| Operating income (loss): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;National Security & Digital | $**191** | $187 | $**564** | $545 |
| &nbsp;&nbsp;&nbsp;Health & Civil | **328** | 287 | **938** | 816 |
| &nbsp;&nbsp;&nbsp;Commercial & International | **38** | 41 | **115** | 64 |
| &nbsp;&nbsp;&nbsp;Defense Systems | **37** | 37 | **112** | 92 |
| &nbsp;&nbsp;&nbsp;Corporate | **(59)** | (36) | **(93)** | (111) |
| Total | $**535** | $516 | $**1636** | $1406 |
| Operating income margin: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;National Security & Digital | **9.5%** | 10.0% | **9.8%** | 10.0% |
| &nbsp;&nbsp;&nbsp;Health & Civil | **25.2%** | 23.4% | **24.3%** | 22.1% |
| &nbsp;&nbsp;&nbsp;Commercial & International | **6.7%** | 7.1% | **6.7%** | 3.9% |
| &nbsp;&nbsp;&nbsp;Defense Systems | **6.4%** | 7.1% | **6.9%** | 6.2% |
| Total | **12.0%** | 12.3% | **12.6%** | 11.4% |

---

**National Security & Digital**

National Security & Digital revenues of $2.02 billion increased by 8% compared to the prior year quarter. Revenue growth was driven by recent contract awards and increased volumes for Defense IT and Intelligence Community mission support, as well as $26 million from the acquisition of Kudu Dynamics. For the quarter, operating income margin decreased modestly to 9.5% from 10.0% in the prior year quarter. Similarly, non-GAAP operating income margin of 10.0% was down from 10.5% in the prior year quarter.

**Health & Civil**

Health & Civil revenues of $1.30 billion increased by 6% compared to the prior year quarter. Health & Civil operating income margin for the quarter was 25.2%, compared to 23.4% in the prior year quarter, and non-GAAP operating income margin was 25.7%, up from 24.2% in the prior year quarter. The increased profitability was driven by continued high volumes and the timing of incentive awards within the managed health services business.

**Commercial & International**

Commercial & International revenues of $571 million decreased by 1% compared to the prior year quarter driven primarily by product mix within the security products business, partially offset by continued demand for Energy Infrastructure engineering services. Operating income margin for the quarter was 6.7%, compared to 7.1% in the prior year quarter, and non-GAAP operating margin decreased to 8.1% from 8.8% in the prior year quarter.

**Defense Systems**

Defense Systems revenues of $582 million increased by 11% compared to the prior year quarter, primarily driven by increased volumes in integrated air defense, including the Indirect Fires Protection Capability Increment 2 system and radar surveillance systems. Defense Systems operating income margin for the quarter was 6.4%, compared to 7.1% in the prior year quarter, and non-GAAP operating margin was 8.9%, compared to 10.2% in the prior year quarter. The lower profitability resulted from a higher mix of materials consistent with the initial phases of production on multiple production programs.

Leidos Holdings, Inc. Exhibit 99.1 10

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED BACKLOG BY REPORTABLE SEGMENT**

Backlog represents the revenues we expect to recognize under negotiated contracts and unissued task orders on sole source IDIQ contracts, to the extent we believe their execution and funding to be probable. Backlog does not include potential task orders expected to be awarded under multiple award IDIQ contracts.

Backlog value is based on management's estimates about volume of services, availability of customer funding and other factors, and excludes contracts that are under protest. Estimated backlog comprises both funded and negotiated unfunded backlog. Backlog estimates are subject to change and may be affected by several factors, including modifications of contracts, non-exercise of options and foreign currency movements.

Funded backlog for contracts with the U.S. government represents the value on contracts for which funding is appropriated less revenues previously recognized on these contracts. Funded backlog for contracts with non-U.S. government entities and commercial customers represents the estimated value on contracts, which may cover multiple future years, under which Leidos is obligated to perform, less revenue previously recognized on the contracts. Unfunded backlog represents all remaining value on task orders that is not funded, including options, that we expect to recognize as well as expected future task orders under sole source IDIQ contracts.

The estimated value of backlog as of the dates presented was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **October 3, 2025** | **October 3, 2025** | **October 3, 2025** | September 27, 2024<sup>(1)</sup> | September 27, 2024<sup>(1)</sup> | September 27, 2024<sup>(1)</sup> |
| (in millions) | **Funded** | **Unfunded** | **Total** | Funded | Unfunded | Total |
| National Security & Digital | $**3203** | $**23246** | $**26449** | $3323 | $20908 | $24231 |
| Health & Civil | **1866** | **9043** | **10909** | 1536 | 10002 | 11538 |
| Commercial & International | **2549** | **2398** | **4947** | 2631 | 2022 | 4653 |
| Defense Systems | **1446** | **3905** | **5351** | 1602 | 3489 | 5091 |
| Total | $**9064** | $**38592** | $**47656** | $9092 | $36421 | $45513 |

---

<sup>(1)</sup> Amounts have been recast to include estimated future revenue on task orders expected to be awarded under sole source IDIQ contracts. As a result, unfunded backlog increased $4,952 million.

Backlog at October 3, 2025, includes $149 million acquired through the acquisition of Kudu Dynamics within our National Security & Digital reportable segment.

11 Leidos Holdings, Inc. Exhibit 99.1

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED NON-GAAP FINANCIAL MEASURES**

Leidos uses and refers to non-GAAP operating income, non-GAAP operating margin, adjusted EBITDA, adjusted EBITDA margin, non-GAAP diluted EPS, non-GAAP free cash flow and non-GAAP free cash flow conversion, which are not measures of financial performance under generally accepted accounting principles in the U.S. and, accordingly, these measures should not be considered in isolation or as a substitute for the comparable GAAP measures and should be read in conjunction with Leidos's consolidated financial statements prepared in accordance with GAAP.

Management believes that these non-GAAP measures provide another representation of the results of operations and financial condition, including its ability to comply with financial covenants. These non-GAAP measures are frequently used by financial analysts covering Leidos and its peers. The computation of non-GAAP measures may not be comparable to similarly titled measures reported by other companies, thus limiting their use for comparability.

**Organic revenues** capture the revenue that is inherent in the underlying business excluding the impact of acquisitions and divestitures made within the prior year; it is computed as current revenues excluding revenues from acquisitions within the last 12 months and divestitures within the current and year-ago periods.

**Non-GAAP operating income** is computed by excluding the following discrete items from operating income:

►Acquisition, integration and restructuring costs – Represents acquisition, integration, lease termination, severance and retention costs and asset markdowns related to acquisitions and restructuring activities.

►Amortization of acquired intangible assets – Represents the amortization of the fair value of the acquired intangible assets.

►Gain on sale of intangible assets – Represents the gain on sale of intellectual property not used in operations.

►Asset impairment charges – Represents impairments of long-lived intangible assets, right-of-use assets, and other assets related to our facility rationalization effort.

**Non-GAAP operating margin** is computed by dividing non-GAAP operating income by revenues.

**Adjusted EBITDA** is computed by excluding the following items from income before income taxes: (i) discrete items as identified above; (ii) interest expense; (iii) interest income; (iv) depreciation expense; and (v) amortization of internally developed intangible assets.

**Adjusted EBITDA margin** is computed by dividing adjusted EBITDA by revenues.

**Non-GAAP net income** is computed by excluding the discrete items listed under non-GAAP operating income and their related tax impacts.

**Non-GAAP diluted EPS** is computed by dividing net income attributable to Leidos common stockholders, adjusted for the discrete items as identified above and the related tax impacts, by the diluted weighted average number of common shares outstanding.

**Non-GAAP free cash flow** is computed by deducting expenditures for property, equipment and software from net cash provided by (used in) operating activities.

**Non-GAAP free cash flow conversion** is computed by dividing non-GAAP free cash flow by non-GAAP net income attributable to Leidos common stockholders; operating cash flow conversion is computed by dividing net cash provided by (used in) operating activities by net income attributable to Leidos shareholders.

Leidos Holdings, Inc. Exhibit 99.1 12

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]**

(in millions, except growth percentages)

The following table presents the reconciliation of revenues to organic revenues by reportable segment and total operations:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **October 3, 2025** | September 27, 2024 | Percent Change |
| National Security & Digital |  |  |  |
| &nbsp;&nbsp;&nbsp;Revenues, as reported | $**2015** | $1865 | 8.0% |
| &nbsp;&nbsp;Acquisition revenues<sup>(1)</sup> | **26** |  |  |
| Organic revenues | **1989** | 1865 | 6.6% |
| Health & Civil |  |  |  |
| &nbsp;&nbsp;&nbsp;Revenues, as reported | **1301** | 1225 | 6.2% |
| Commercial & International |  |  |  |
| &nbsp;&nbsp;&nbsp;Revenues, as reported | **571** | 578 | (1.2)% |
| Defense Systems |  |  |  |
| &nbsp;&nbsp;&nbsp;Revenues, as reported | **582** | 522 | 11.5% |
| Total Operations |  |  |  |
| &nbsp;&nbsp;&nbsp;Revenues, as reported | **4469** | 4190 | 6.7% |
| &nbsp;&nbsp;Acquisition revenues<sup>(1)</sup> | **26** |  |  |
| Organic revenues | $**4443** | $4190 | 6.0% |

---

<sup>(1)</sup> Current period acquisition revenues reflect revenues in the current as reported figures for 12 months from closing of each acquisition. Acquisition revenues for the three months ended October 3, 2025, for the National Security & Digital segment include Kudu Dynamics (acquired May 23, 2025).

13 Leidos Holdings, Inc. Exhibit 99.1

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]**

(in millions, except per share data and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the **three months** ended October 3, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** |
| | **As reported** | Acquisition, integration and restructuring costs | Amortization of acquired intangibles | Asset impairment charges | **Non-GAAP results** |
| Operating income | $**535** | $4 | $33 | $3 | $**575** |
| Non-operating expense, net | **(51)** |  |  |  | **(51)** |
| Income before income taxes | **484** | 4 | 33 | 3 | **524** |
| Income tax expense<sup>(1)</sup> | **(115)** | (1) | (8) | (1) | **(125)** |
| &nbsp;&nbsp;&nbsp;Net income | **369** | 3 | 25 | $2 | **399** |
| &nbsp;&nbsp;Less: net income attributable to non-controlling interest | **2** |  |  |  | **2** |
| Net income attributable to Leidos common stockholders | $**367** | $3 | $25 | $2 | $**397** |
| Diluted EPS attributable to Leidos common stockholders<sup>(2)</sup> | $**2.82** | $0.02 | $0.19 | $0.02 | $**3.05** |
| Diluted shares | **130** | 130 | 130 | 130 | **130** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** |
| | **As reported** | Acquisition, integration and restructuring costs | Amortization of acquired intangibles | Asset impairment charges | **Non-GAAP results** |
| Net income | $**369** | $3 | $25 | $2 | $**399** |
| Income tax expense<sup>(1)</sup> | **115** | 1 | 8 | 1 | **125** |
| Income before income taxes | **484** | 4 | 33 | 3 | **524** |
| Depreciation expense | **40** |  |  |  | **40** |
| Amortization of intangibles | **34** |  | (33) |  | **1** |
| Interest expense, net | **51** |  |  |  | **51** |
| Adjusted EBITDA | $**609** | $4 | $— | $3 | $**616** |
| Adjusted EBITDA margin | **13.6%** |  |  |  | **13.8%** |

---

<sup>(1)</sup> Calculation uses an estimated statutory tax rate on non-GAAP adjustments.

<sup>(2)</sup> Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.

Leidos Holdings, Inc. Exhibit 99.1 14

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]**

(in millions, except per share data and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the **three months** ended September 27, 2024:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 |
| | As reported | Acquisition, integration and restructuring costs | Amortization of acquired intangibles | Asset impairment charges | Non-GAAP results |
| Operating income | $516 | $3 | $37 | $6 | $562 |
| Non-operating expense, net | (46) |  |  |  | (46) |
| Income before income taxes | 470 | 3 | 37 | 6 | 516 |
| Income tax expense<sup>(1)</sup> | (108) | (1) | (9) | (2) | (120) |
| &nbsp;&nbsp;Net income | 362 | 2 | 28 | 4 | 396 |
| &nbsp;&nbsp;Less: net loss attributable to non-controlling interest | (2) |  |  |  | (2) |
| Net income attributable to Leidos common stockholders | $364 | $2 | $28 | $4 | $398 |
| Diluted EPS attributable to Leidos common stockholders<sup>(2)</sup> | $2.68 | $0.01 | $0.21 | $0.03 | $2.93 |
| Diluted shares | 136 | 136 | 136 | 136 | 136 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 |
| | As reported | Acquisition, integration and restructuring costs | Amortization of acquired intangibles | Asset impairment charges | Non-GAAP results |
| Net income | $362 | $2 | $28 | $4 | $396 |
| Income tax expense<sup>(1)</sup> | 108 | 1 | 9 | 2 | 120 |
| Income before income taxes | 470 | 3 | 37 | 6 | 516 |
| Depreciation expense | 34 |  |  |  | 34 |
| Amortization of intangibles | 37 |  | (37) |  |  |
| Interest expense, net | 46 |  |  |  | 46 |
| Adjusted EBITDA | $587 | $3 | $— | $6 | $596 |
| Adjusted EBITDA margin | 14.0% |  |  |  | 14.2% |

---

<sup>(1)</sup> Calculation uses an estimated statutory tax rate on non-GAAP adjustments.

<sup>(2)</sup> Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.

15 Leidos Holdings, Inc. Exhibit 99.1

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]**

(in millions, except per share data and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the nine months ended October 3, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** |
| | **As reported** | Acquisition, integration and restructuring costs<sup>(1)</sup> | Amortization of acquired intangibles | Asset impairment charges | **Non-GAAP results** |
| Operating income | $**1636** | $11 | $95 | $3 | $**1745** |
| Non-operating expense, net | **(156)** |  |  |  | **(156)** |
| Income before income taxes | **1480** | 11 | 95 | 3 | **1589** |
| Income tax expense<sup>(2)</sup> | **(353)** | (2) | (24) | (1) | **(380)** |
| &nbsp;&nbsp;&nbsp;Net income | **1127** | 9 | 71 | $2 | **1209** |
| &nbsp;&nbsp;Less: net income attributable to non-controlling interest | **6** |  |  |  | **6** |
| Net income attributable to Leidos common stockholders | $**1121** | $9 | $71 | $2 | $**1203** |
| Diluted EPS attributable to Leidos common stockholders<sup>(3)</sup> | $**8.62** | $0.07 | $0.55 | $0.02 | $**9.25** |
| Diluted shares | **130** | 130 | 130 | 130 | **130** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** |
| | **As reported** | Acquisition, integration and restructuring costs<sup>(1)</sup> | Amortization of acquired intangibles | Asset impairment charges | **Non-GAAP results** |
| Net income | $**1127** | $9 | $71 | $2 | $**1209** |
| Income tax expense<sup>(2)</sup> | **353** | 2 | 24 | 1 | **380** |
| Income before income taxes | **1480** | 11 | 95 | 3 | **1589** |
| Depreciation expense | **119** |  |  |  | **119** |
| Amortization of intangibles | **96** |  | (95) |  | **1** |
| Interest expense, net | **155** |  |  |  | **155** |
| Adjusted EBITDA | $**1850** | $11 | $— | $3 | $**1864** |
| Adjusted EBITDA margin | **14.3%** |  |  |  | **14.4%** |

---

<sup>(1)</sup> Asset markdowns associated with restructuring activities were recorded to "Cost of revenues" in the condensed consolidated statements of operations.

<sup>(2)</sup> Calculation uses an estimated statutory tax rate on non-GAAP adjustments.

<sup>(3)</sup> Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.

Leidos Holdings, Inc. Exhibit 99.1 16

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]**

(in millions, except per share data and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the nine months ended September 27, 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 |
| | As reported | Acquisition, integration and restructuring costs<sup>(1)</sup> | Amortization of acquired intangibles | Asset impairment charges | Gain on sale of intangible assets | Non-GAAP results |
| Operating income | $1406 | $20 | $110 | $6 | $— | $1542 |
| Non-operating expense, net | (142) |  |  |  | (2) | (144) |
| Income before income taxes | 1264 | 20 | 110 | 6 | (2) | 1398 |
| Income tax expense<sup>(2)</sup> | (295) | (4) | (28) | (2) |  | (329) |
| &nbsp;&nbsp;Net income | 969 | 16 | 82 | 4 | (2) | 1069 |
| &nbsp;&nbsp;Less: net loss attributable to non-controlling interest | (1) |  |  |  |  | (1) |
| Net income attributable to Leidos common stockholders | $970 | $16 | $82 | $4 | $(2) | $1070 |
| Diluted EPS attributable to Leidos common stockholders<sup>(3)</sup> | $7.13 | $0.12 | $0.60 | $0.03 | $(0.01) | $7.87 |
| Diluted shares | 136 | 136 | 136 | 136 | 136 | 136 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 |
| | As reported | Acquisition, integration and restructuring costs<sup>(1)</sup> | Amortization of acquired intangibles | Asset impairment charges | Gain on sale of intangible assets | Non-GAAP results |
| Net income | $969 | $16 | $82 | $4 | $(2) | $1069 |
| Income tax expense<sup>(2)</sup> | 295 | 4 | 28 | 2 |  | 329 |
| Income before income taxes | 1264 | 20 | 110 | 6 | (2) | 1398 |
| Depreciation expense | 101 |  |  |  |  | 101 |
| Amortization of intangibles | 110 |  | (110) |  |  |  |
| Interest expense, net | 146 |  |  |  |  | 146 |
| Adjusted EBITDA | $1621 | $20 | $— | $6 | $(2) | $1645 |
| Adjusted EBITDA margin | 13.2% |  |  |  |  | 13.4% |

---

<sup>(1)</sup> Asset markdowns associated with restructuring activities were recorded to "Cost of revenues" in the condensed consolidated statements of operations.

<sup>(2)</sup> Calculation uses an estimated statutory tax rate on non-GAAP adjustments.

<sup>(3)</sup> Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.

17 Leidos Holdings, Inc. Exhibit 99.1

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]**

(in millions, except margin percentages)

The following tables present the reconciliation of non-GAAP operating income by reportable segment and Corporate to operating income:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** | **Three Months Ended October 3, 2025** |
| | **Operating income (loss)** | Acquisition, integration and restructuring costs | Amortization of acquired intangibles | Asset impairment charges | **Non-GAAP operating income (loss)** | **Non-GAAP operating margin** |
| National Security & Digital | $**191** | $2 | $8 | $— | $**201** | **10.0%** |
| Health & Civil | **328** |  | 6 |  | **334** | **25.7%** |
| Commercial & International | **38** | 1 | 7 |  | **46** | **8.1%** |
| Defense Systems | **37** |  | 12 | 3 | **52** | **8.9%** |
| Corporate | **(59)** | 1 |  |  | **(58)** | ***NM*** |
| Total | $**535** | $4 | $33 | $3 | $**575** | **12.9%** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 | Three Months Ended September 27, 2024 |
| | Operating income<br> (loss) | Acquisition, integration and restructuring costs | Amortization of acquired intangibles | Asset impairment charges | Non-GAAP operating income<br> (loss) | Non-GAAP operating margin |
| National Security & Digital | $187 | $— | $6 | $2 | $195 | 10.5% |
| Health & Civil | 287 |  | 8 | 2 | 297 | 24.2% |
| Commercial & International | 41 | 1 | 7 | 2 | 51 | 8.8% |
| Defense Systems | 37 |  | 16 |  | 53 | 10.2% |
| Corporate | (36) | 2 |  |  | (34) | *NM* |
| Total | $516 | $3 | $37 | $6 | $562 | 13.4% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** | **Nine Months Ended October 3, 2025** |
| | **Operating income (loss)** | Acquisition, integration and restructuring costs<sup>(1)</sup> | Amortization of acquired intangibles | Asset impairment charges | **Non-GAAP operating income (loss)** | **Non-GAAP operating margin** |
| National Security & Digital | $**564** | $2 | $20 | $— | $**586** | **10.2%** |
| Health & Civil | **938** |  | 18 |  | **956** | **24.7%** |
| Commercial & International | **115** | 6 | 21 |  | **142** | **8.3%** |
| Defense Systems | **112** |  | 36 | 3 | **151** | **9.2%** |
| Corporate | **(93)** | 3 |  |  | **(90)** | ***NM*** |
| Total | $**1636** | $11 | $95 | $3 | $**1745** | **13.5%** |

---

NM - Not Meaningful

<sup>(1)</sup> Asset markdowns associated with restructuring activities were recorded to "Cost of revenues" in the condensed consolidated statements of operations.

Leidos Holdings, Inc. Exhibit 99.1 18

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]**

(in millions, except margin percentages)

The following tables present the reconciliation of non-GAAP operating income by reportable segment and Corporate to operating income:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 | Nine Months Ended September 27, 2024 |
| | Operating income <br>(loss) | Acquisition, integration and restructuring costs | Amortization of acquired intangibles | Asset impairment charges | Non-GAAP operating income <br>(loss) | Non-GAAP operating margin |
| National Security & Digital | $545 | $— | $17 | $2 | $564 | 10.3% |
| Health & Civil | 816 |  | 21 | 2 | 839 | 22.8% |
| Commercial & International | 64 | 9 | 22 | 2 | 97 | 5.9% |
| Defense Systems | 92 |  | 50 |  | 142 | 9.5% |
| Corporate | (111) | 11 |  |  | (100) | *NM* |
| Total | $1406 | $20 | $110 | $6 | $1542 | 12.5% |

---

NM - Not Meaningful

19 Leidos Holdings, Inc. Exhibit 99.1

------

**LEIDOS HOLDINGS, INC.**

**UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]**

(in millions, except percentages)

The following table presents the reconciliation of free cash flow to net cash provided by operating activities as well as the calculation of operating cash flow and free cash flow conversion ratios:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **October 3, 2025** | September 27, 2024 |
| Net cash provided by operating activities<sup>(1)</sup> | $**711** | $647 |
| Payments for property, equipment and software | **(31)** | (23) |
| Non-GAAP free cash flow | $**680** | $624 |
| Net income attributable to Leidos common stockholders | $**367** | $364 |
| Acquisition, integration and restructuring costs<sup>(2)</sup> | **3** | 2 |
| Amortization of acquired intangibles<sup>(2)</sup> | **25** | 28 |
| Asset impairment charges<sup>(2)</sup> | **2** | 4 |
| Non-GAAP net income attributable to Leidos common stockholders | $**397** | $398 |
| Operating cash flow conversion ratio | **194%** | 178% |
| Non-GAAP free cash flow conversion ratio | **171%** | 157% |

---

<sup>(1)</sup> Net cash provided by operating activities for the three months ended September 27, 2024, was recast to reflect a change in accounting policy.

<sup>(2)</sup> After-tax expenses excluded from non-GAAP net income.

Leidos Holdings, Inc. Exhibit 99.1 20